Juliano, Mario2013-09-132013-09-132013-05https://hdl.handle.net/11299/156768University of Minnesota M.S. thesis. May 2013. Major: Stem cell biology. Advisor: Andrew Grande. 1 computer file (PDF); iv, 54 pages.Stroke is one of the leading causes of death in the United States. Limitations of currently available stroke treatment include a 3 hour time window for recombinant tissue plasminogen activator. Stem cells have become promising for the treatment of a variety of neurodegenerative diseases, including stroke. Therapies in this category include stimulation of endogenous neurogenesis, as well as the delivery of exogenous stem cells.This thesis focuses on the investigation of the intravenous delivery of a CD34 negative subset of umbilical cord blood stem cells as a therapy for stroke. Methods employed for this investigation include next generation sequencing technologies for gene expression profiling, 19-fluorine tracking of stem cells with MRI, and fluorescence biodistribution tracking.en-USMRINGSStem cell biologyStrokeThesis or Dissertation